Skip to main content

Table 1 Associations of sociodemographic and clinical characteristics with non-CSD

From: Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis

Variable

No. (%)

Univariate Analysis

Multivariate Analysis

 

Total

Alive

CSD

Non-CSD

OR (95% CI)

p-value

OR (95% CI)

p-value

Age, years

 20–39 (youngest)

10,556

8332 (78.9)

1302 (12.3)

922 (8.7)

Reference

 

Reference

 

 40–59 (older)

4734

2758 (58.2)

1011 (21.4)

965 (20.4)

2.68 (2.43–2.95)

< 0.001

3.05 (2.74–3.39)

< 0.001

  ≥ 60 (oldest)

3228

443 (13.7)

1455 (45.1)

1330 (41.2)

7.32 (6.64–8.07)

< 0.001

8.60 (7.70–9.62)

< 0.001

Period

 1983–1992

5022

2282 (45.4)

1331 (26.5)

1409 (28.1)

Reference

 

Reference

 

 1993–2000

5743

3621 (63.0)

1142 (19.9)

980 (17.1)

0.53 (0.48–0.58)

< 0.001

0.50 (0.43–0.56)

< 0.001

 2001–2005

7753

5640 (72.2)

1295 (16.7)

818 (10.6)

0.31 (0.28–0.34)

< 0.001

0.28 (0.25–0.31)

< 0.001

Sex

 Male

9998

5734 (57.4)

2270 (22.7)

1994 (19.9)

Reference

 

Reference

 

 Female

8520

5799 (68.0)

1498 (17.6)

1223 (14.4)

0.67 (0.62–0.73)

< 0.001

0.68 (0.62–0.74)

< 0.001

Race

 White

16,082

10,070 (62.6)

3180 (19.8)

2832 (17.6)

Reference

 

Reference

 

 Black

1694

990 (58.4)

430 (25.4)

274 (16.2)

0.90 (0.79–1.03)

0.139

1.13 (0.97–1.31)

0.117

 Others

742

473 (63.7)

158 (21.3)

111 (15.0)

0.82 (0.67–1.01)

0.064

0.91 (0.72–1.14)

0.396

Marital status

 Married

9789

6023 (61.6)

1921 (19.6)

1845 (18.8)

Reference

 

Reference

 

 Unmarried

8729

5630 (64.5)

1727 (19.8)

1372 (15.7)

0.80 (0.74–0.87)

< 0.001

1.132 (1.04–1.23)

0.005

Histological type

 NS

13,562

9362 (69.1)

2284 (16.8)

1916 (14.1)

Reference

 

Reference

 

 MC

3804

1658 (43.5)

1117 (29.4)

1029 (27.1)

2.25 (2.07–2.46)

< 0.001

1.19 (1.08–1.31)

< 0.001

 LR

729

408 (56.0)

147 (20.1)

174 (23.9)

1.91 (1.60–2.28)

< 0.001

1.09 (0.89–1.32)

0.413

 LD

423

105 (24.8)

220 (52.0)

98 (23.2)

1.83 (1.46–2.31)

< 0.001

0.67 (0.52–0.87)

0.002

Ann Arbor stage

 Early

11,744

8034 (68.4)

1740 (14.8)

1970 (16.8)

Reference

 

Reference

 

 Advanced

6774

3565 (52.6)

1962 (28.9)

1247 (18.5)

1.12 (1.04–1.21)

< 0.001

0.92 (0.85–1.02)

0.393

Therapy

 Combined modality

5410

4196 (77.6)

633 (11.7)

581 (10.7)

Reference

 

Reference

 

 RT only

2985

1707 (57.2)

461 (15.4)

817 (27.4)

3.13 (2.78–3.52)

< 0.001

1.64 (1.43–1.88)

< 0.001

 CT only

8013

4501 (56.1)

2113 (26.4)

1399 (17.5)

1.76 (1.59–1.95)

< 0.001

1.08 (0.97–1.22)

0.175

 No/unknown

2110

1129 (53.5)

561 (26.6)

420 (19.9)

2.07 (1.80–2.37)

< 0.001

1.09 (0.94–1.27)

0.241